Cargando…
Pulmonary vascular and cardiac impairment in interstitial lung disease
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of...
Autores principales: | Panagiotou, Marios, Church, Alistair C., Johnson, Martin K., Peacock, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488566/ https://www.ncbi.nlm.nih.gov/pubmed/28096284 http://dx.doi.org/10.1183/16000617.0053-2016 |
Ejemplares similares
-
Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease
por: McGettrick, Michael, et al.
Publicado: (2022) -
The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension
por: Church, Alistair C., et al.
Publicado: (2015) -
Right Ventricular free wall myocardial tissue characterisation by systolic Cardiac Magnetic Resonance T1 mapping in pulmonary hypertension
por: Jayasekera, Geeshath, et al.
Publicado: (2016) -
Pulmonary hypertension and pulmonary vascular disease: course report
por: Peacock, Andrew, et al.
Publicado: (2018) -
The obesity paradox in pulmonary arterial hypertension: the Scottish perspective
por: McLean, Luke Lawson, et al.
Publicado: (2019)